Understanding the genetic underpinnings of severe cardiovascular complications could transform how clinicians approach treatment and family counseling for one of childhood's most challenging heart conditions. When children are born with structural heart defects, some develop a devastating secondary condition where lung blood vessels become dangerously narrowed and stiffened, leading to heart failure if untreated.
Genetic analysis of 42 patients with this dual diagnosis revealed that 17 individuals—approximately 40%—carried variants in genes known to influence pulmonary arterial hypertension development. Researchers identified 21 distinct genetic changes across 11 different genes, with BMPR2 and TET2 variants appearing most frequently. Twelve of these variants had never been documented before, expanding the known genetic landscape of this condition. Ventricular septal defects emerged as the most common underlying heart malformation among patients carrying these genetic variants.
This genetic overlap suggests that some individuals may be predisposed to developing pulmonary complications following congenital heart repairs, potentially due to shared molecular pathways governing both heart development and blood vessel function. The finding challenges the traditional view that post-surgical pulmonary hypertension results solely from altered blood flow patterns and surgical interventions. Instead, it points toward inherent genetic vulnerabilities that could be identified early through screening. While this represents relatively small-scale research requiring validation in larger populations, the discovery of novel variants offers promising targets for future therapeutic development. For families affected by congenital heart disease, genetic testing may eventually help predict which children face elevated risks for this serious complication, enabling more personalized monitoring and potentially preventive interventions.